Drug Type Synthetic peptide |
Synonyms Rotigaptide (USAN), GAP-486, WAY 214486 + [3] |
Target |
Action agonists |
Mechanism GJA1 agonists(Gap junction alpha-1 protein agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H39N7O9 |
InChIKeyGFJRASPBQLDRRY-TWTQBQJDSA-N |
CAS Registry355151-12-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05767 | Rotigaptide | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tachycardia, Ventricular | Phase 2 | United States | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Brazil | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Canada | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Croatia | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Denmark | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Hungary | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | India | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Italy | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Mexico | 01 Jun 2005 | |
Tachycardia, Ventricular | Phase 2 | Poland | 01 Jun 2005 |
Not Applicable | 10 | uyngyiuecz(amtqjyhaht) = gsifgzcjmf klztwrzmhp (jgckhjdzof ) | - | 01 Jun 2016 | |||
Placebo | uyngyiuecz(amtqjyhaht) = qsmvqhyhko klztwrzmhp (jgckhjdzof ) |